Status:
COMPLETED
Eliminating Narcotic Prescriptions from Outpatient Minimally Invasive Gynecologic Surgery
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Pain, Postoperative
Opioid Use
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Laparoscopic gynecologic surgeries are generally very well tolerated procedures, and patients are able to go home on the same day, with a prescription for pain control. There is currently a very wide ...
Detailed Description
Narcotic prescribing patterns vary greatly among gynecologists performing minimally invasive gynecologic surgery (MIGS). There is no clear consensus or established guideline regarding the choice of na...
Eligibility Criteria
Inclusion
- Women undergoing elective outpatient gynecologic laparoscopy
- Able to provide informed consent
- Planned for same day discharge
Exclusion
- Chronic pain conditions including, but not limited to: chronic pelvic pain, fibromyalgia, connective tissue disorders, migraines on medication, severe osteoarthritis, sciatica, degenerative disk disease
- Regular use of analgesia or narcotics. Defined as use of pain medication on most days of the week, most weeks of the month
- History of substance abuse (opioid addiction, IV drug use, etc.)
- Known depression or anxiety conditions with or without medication
- Eastern Cooperative Oncology Group (ECOG) performance status 3 or greater
- Current or recent use of pain modulators such as pregabalin or gabapentin (one month pre-operatively).
- Allergy or contraindication to acetaminophen or NSAIDs or hydromorphone/narcotics
- Intraoperative complications :
- Conversion to laparotomy or mini-laparotomy \> 4 cm
- Intra-operative gastrointestinal or urologic injury
- Intra-operative hemorrhage or need for blood transfusion
- Need for admission
Key Trial Info
Start Date :
July 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04837014
Start Date
July 4 2022
End Date
October 21 2024
Last Update
October 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Center
Montreal, Quebec, Canada, H4A 3J1